Nothing Special   »   [go: up one dir, main page]

AU2015201737B2 - Identification of tumour-associated cell surface antigens for diagnosis and therapy - Google Patents

Identification of tumour-associated cell surface antigens for diagnosis and therapy

Info

Publication number
AU2015201737B2
AU2015201737B2 AU2015201737A AU2015201737A AU2015201737B2 AU 2015201737 B2 AU2015201737 B2 AU 2015201737B2 AU 2015201737 A AU2015201737 A AU 2015201737A AU 2015201737 A AU2015201737 A AU 2015201737A AU 2015201737 B2 AU2015201737 B2 AU 2015201737B2
Authority
AU
Australia
Prior art keywords
nucleic acid
tumour
diagnosis
therapy
identification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2015201737A
Other versions
AU2015201737A1 (en
Inventor
Gerd Helftenbein
Ugur Sahin
Volker SCHLÜTER
Özlem TÜRECI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biontech SE
Original Assignee
Biontech SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012233057A external-priority patent/AU2012233057B2/en
Application filed by Biontech SE filed Critical Biontech SE
Priority to AU2015201737A priority Critical patent/AU2015201737B2/en
Publication of AU2015201737A1 publication Critical patent/AU2015201737A1/en
Application granted granted Critical
Publication of AU2015201737B2 publication Critical patent/AU2015201737B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention provides a pharmaceutical composition, comprising an agent which inhibits expression or activity of a tumor-associated antigen, said tumor-associated antigen having a sequence encoded by a nucleic acid which is selected from the group consisting of: (a) a nucleic acid which comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOs: 1, 5, 9, 13, 17, 21, 25, 29, 33, 37, 41, 45, 49, 53, 57, 61, 65, 69, 73, 77, 81, 85, 89, 93, 97, 101, 105, 109, 113, 117, 121, 125, 129, 133, 137, 141, 145, 149, 153, 157, 161, 165, 169, 173, 175, 179, 183, 187, 191, 195, 199, 203, 207, 211, 215, 219, 223, 227, 231, 235, 239, 243, 247, 251, 255, 259, 263, 267, 269, 271, 273, 275, 277, 279, 309 of the sequence listing, a part or derivative thereof, (b) a nucleic acid which hybridizes with the nucleic acid of (a) under stringent conditions, (c) a nucleic acid which is degenerate with respect to the nucleic acid of (a) or (b), and (d) a nucleic acid which is complementary to the nucleic acid of (a) , (b) or (c).
AU2015201737A 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy Expired AU2015201737B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2015201737A AU2015201737B2 (en) 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10344799.7 2003-09-26
AU2012233057A AU2012233057B2 (en) 2003-09-26 2012-09-28 Identification of tumour-associated cell surface antigens for diagnosis and therapy
AU2015201737A AU2015201737B2 (en) 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2012233057A Division AU2012233057B2 (en) 2003-09-26 2012-09-28 Identification of tumour-associated cell surface antigens for diagnosis and therapy

Publications (2)

Publication Number Publication Date
AU2015201737A1 AU2015201737A1 (en) 2015-04-30
AU2015201737B2 true AU2015201737B2 (en) 2016-09-15

Family

ID=53008145

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2015201737A Expired AU2015201737B2 (en) 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy
AU2015201738A Expired AU2015201738B2 (en) 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2015201738A Expired AU2015201738B2 (en) 2003-09-26 2015-04-07 Identification of tumour-associated cell surface antigens for diagnosis and therapy

Country Status (1)

Country Link
AU (2) AU2015201737B2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2478413A1 (en) * 2002-03-13 2003-09-18 Ganymed Pharmaceuticals Ag Genetic products differentially expressed in tumors and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281059A1 (en) * 1997-02-24 1998-08-27 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO2001060860A2 (en) * 2000-02-17 2001-08-23 Millennium Predictive Medicine, Inc. Genes differentially expressed in human prostate cancer and their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2478413A1 (en) * 2002-03-13 2003-09-18 Ganymed Pharmaceuticals Ag Genetic products differentially expressed in tumors and use thereof

Also Published As

Publication number Publication date
AU2015201738A1 (en) 2015-04-30
AU2015201737A1 (en) 2015-04-30
AU2015201738B2 (en) 2016-10-13

Similar Documents

Publication Publication Date Title
WO2003049762A3 (en) Immunisation against chlamydia trachomatis
WO2001070174A8 (en) Vegf-modulated genes and methods employing them
NZ513498A (en) Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
NZ594877A (en) Nucleic acids and proteins from streptococcus groups A & B
ITFI920052A1 (en) PROTEIN EXTRACTED FROM HELICOBACTER PYLORI CYTOTOXIC STRAINS, GENE THAT EXPRESSES IT, USE OF PROTEIN AS VACCINE OR DIAGNOSTIC.
WO2001046224A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000066739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2002061076A1 (en) Adiponectin-associated protein
IL135687A0 (en) A novel human checkpoint kinase, hcds1, compositions and methods
NZ526879A (en) Genes and proteins, and their use
HU228469B1 (en) Attenuated pestiviruses, their use, and nuclein acids for their production
WO1999028439A3 (en) Erythrovirus and its applications
DE60332425D1 (en) 5T4-ANTIGEN-PEPTIDEPITOPES OF MHC CLASS II
AU2015201737B2 (en) Identification of tumour-associated cell surface antigens for diagnosis and therapy
EP2172214A3 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU2005203173A1 (en) Super-antigen fusion proteins and the use thereof
MXPA01004353A (en) Chlamydia.
WO1998004585A3 (en) Novel human macrophage antigen
WO2000006742A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2004046326A3 (en) Modulation of interleukin 22 receptor expression
PL370854A1 (en) Ee3-protein family and corresponding dna sequences
WO2002086067A3 (en) Mycobacterial sulfation pathway proteins and methods of use thereof
WO2000009711A3 (en) ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
MXPA01001639A (en) Chlamydia.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired